{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:15:44Z","timestamp":1775682944197,"version":"3.50.1"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03AG078804"],"award-info":[{"award-number":["R03AG078804"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K76AG088411"],"award-info":[{"award-number":["K76AG088411"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R03AG082859"],"award-info":[{"award-number":["R03AG082859"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG044281"],"award-info":[{"award-number":["P30AG044281"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG080163"],"award-info":[{"award-number":["K23AG080163"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG073523"],"award-info":[{"award-number":["K23AG073523"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG066605"],"award-info":[{"award-number":["P01AG066605"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["2K24AG049057"],"award-info":[{"award-number":["2K24AG049057"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P01AG066605"],"award-info":[{"award-number":["P01AG066605"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R33AG086944"],"award-info":[{"award-number":["R33AG086944"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["KL2TR001870"],"award-info":[{"award-number":["KL2TR001870"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Affairs Center for Medication Safety in Aging"},{"name":"Veteran Affairs National Center for Patient Safety"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Loop diuretic (LD) use may lead to a prescribing cascade whereby urinary symptoms are ascribed to genitourinary syndromes and treated with urinary symptom medications (USMs). We investigated if LDs lead to increased USM use among older adults and whether this potential prescribing cascade varies across key characteristics.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was a prescription sequence symmetry analysis of Veterans Administration data, involving veterans \u226566 years who initiated treatment with LD (2010-2019). USMs were antimuscarinics, beta-3 adrenergic agonists, peripheral alpha-1 blockers, and 5-alpha reductase inhibitors. We calculated the adjusted sequence ratio (aSR), assessing the cascade signal while adjusting for secular trends, and stratified by key variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>There were 17 735 veterans who initiated USM within 6 months after LD and 25 190 who initiated USM within 6 months before LD; 99% were male. Unexpectedly, the aSR was 0.74 (95% CI, 0.73-0.76), meaning patients were 26% less likely to initiate USM within 6 months after initiating LD versus 6 months before. This inverse relationship held in men (aSR, 0.74, 95% CI, 0.72-0.76) but was null in women (aSR, 1.00, 95% CI, 0.80-1.26). In men without baseline urinary symptoms, we observed the LD\u2013USM cascade in patients with heart failure (aSR 1.52, 95% CI, 1.41-1.63) and multimorbidity (eg, Charlson fourth quartile, aSR 1.24, 95% CI, 1.10-1.39).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>We did not find evidence for an LD\u2013USM cascade among predominantly male older adults overall. Clinicians may underprescribe USMs in patients receiving LDs, perhaps due to strong attribution of urinary symptoms to LD use.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/gerona\/glaf150","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T14:50:33Z","timestamp":1752677433000},"source":"Crossref","is-referenced-by-count":1,"title":["Loop diuretics and subsequent use of urinary symptom medications in older adults: evaluation of a possible prescribing cascade"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5997-4406","authenticated-orcid":false,"given":"Matthew E","family":"Growdon","sequence":"first","affiliation":[{"name":"Division of Geriatrics, University of California , San Francisco , San Francisco, California,","place":["United States"]},{"name":"San Francisco Veterans Affairs Medical Center , San Francisco, California,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bocheng","family":"Jing","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, University of California , San Francisco , San Francisco, California,","place":["United States"]},{"name":"San Francisco Veterans Affairs Medical Center , San Francisco, California,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7947-3008","authenticated-orcid":false,"given":"W James","family":"Deardorff","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, University of California , San Francisco , San Francisco, California,","place":["United States"]},{"name":"San Francisco Veterans Affairs Medical Center , San Francisco, California,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6092-8906","authenticated-orcid":false,"given":"Earl J","family":"Morris","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Outcomes & Policy, University of Florida College of Pharmacy , Gainesville, Florida,","place":["United States"]},{"name":"Center for Drug Evaluation and Safety, University of Florida , Gainesville, Florida,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W John","family":"Boscardin","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, University of California , San Francisco , San Francisco, California,","place":["United States"]},{"name":"Department of Epidemiology and Biostatistics, University of California , San Francisco , San Francisco, California,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8719-6752","authenticated-orcid":false,"given":"Leah J","family":"Blank","sequence":"additional","affiliation":[{"name":"Department of Neurology, Icahn School of Medicine at Mount Sinai , New York, New York,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasce","family":"Bongiovanni","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of California , San Francisco , San Francisco, California,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1165-5558","authenticated-orcid":false,"given":"Kenneth S","family":"Boockvar","sequence":"additional","affiliation":[{"name":"Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham , Birmingham, Alabama,","place":["United States"]},{"name":"Geriatrics Research Education and Clinical Center , Birmingham VA , Birmingham, Alabama,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9564-9480","authenticated-orcid":false,"given":"Michael A","family":"Steinman","sequence":"additional","affiliation":[{"name":"Division of Geriatrics, University of California , San Francisco , San Francisco, California,","place":["United States"]},{"name":"San Francisco Veterans Affairs Medical Center , San Francisco, California,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"2025081221214026700_glaf150-B1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s40266-013-0145-1","article-title":"Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence","volume":"31","author":"Tannenbaum","year":"2014","journal-title":"Drugs Aging."},{"key":"2025081221214026700_glaf150-B2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1007\/s11934-009-0069-9","article-title":"The association between overactive bladder and diuretic use in the elderly","volume":"10","author":"Ekundayo","year":"2009","journal-title":"Curr Urol Rep."},{"key":"2025081221214026700_glaf150-B3","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.3390\/ph16071031","article-title":"Lower urinary tract disorders as adverse drug reactions\u2014a literature review","volume":"16","author":"Dobrek","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"2025081221214026700_glaf150-B4","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1111\/jgs.12741","article-title":"Risk of Medication-associated initiation of oxybutynin in elderly men and women","volume":"62","author":"Kalisch Ellett","year":"2014","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B5","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/gerona\/gls177","article-title":"Antihypertensive drug class use and differential risk of urinary incontinence in community-dwelling older women","volume":"67","author":"Peron","year":"2012","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2025081221214026700_glaf150-B6","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2165\/00002512-200825070-00001","article-title":"Drug-induced urinary incontinence","volume":"25","author":"Tsakiris","year":"2008","journal-title":"Drugs Aging"},{"key":"2025081221214026700_glaf150-B7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s11136-010-9808-0","article-title":"The prevalence of urinary incontinence and its burden on the quality of life among older adults with Medicare supplement insurance","volume":"20","author":"Hawkins","year":"2011","journal-title":"Qual Life Res."},{"key":"2025081221214026700_glaf150-B8","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1111\/jgs.12408","article-title":"Effect of urinary incontinence on older nursing home residents\u2019 self-reported quality of life","volume":"61","author":"Xu","year":"2013","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B9","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/HYPERTENSIONAHA.118.12495","article-title":"Antihypertensive medication nonpersistence and low adherence for adults &lt;65 years initiating treatment in 2007-2014","volume":"74","author":"Tajeu","year":"2019","journal-title":"Hypertension"},{"key":"2025081221214026700_glaf150-B10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/JCN.0000000000000616","article-title":"Medication nonadherence or self-care? understanding the medication decision-making process and experiences of older adults with heart failure","volume":"35","author":"Meraz","year":"2020","journal-title":"J Cardiovasc Nurs"},{"key":"2025081221214026700_glaf150-B11","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s40266-022-00964-9","article-title":"ThinkCascades: a tool for identifying clinically important prescribing cascades affecting older people","volume":"39","author":"McCarthy","year":"2022","journal-title":"Drugs Aging."},{"key":"2025081221214026700_glaf150-B12","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/jgs.15800","article-title":"Assessing the scope and appropriateness of prescribing cascades","volume":"67","author":"McCarthy","year":"2019","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.urology.2008.03.057","article-title":"Prevalence and characteristics of lower urinary tract symptoms in men aged 80 years and older","volume":"72","author":"Parsons","year":"2008","journal-title":"Urology."},{"key":"2025081221214026700_glaf150-B14","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.urology.2006.04.019","article-title":"Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study","volume":"68","author":"Taylor","year":"2006","journal-title":"Urology."},{"key":"2025081221214026700_glaf150-B15","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1093\/ajh\/hpae139","article-title":"Bladder symptoms provoked by short, rapid-acting loop diuretics: a frequent but often overlooked problem","volume":"38","author":"Wilcox","year":"2025","journal-title":"Am J Hypertens."},{"key":"2025081221214026700_glaf150-B16","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s41999-023-00798-7","article-title":"Management of use of urinary antimuscarinics and alpha blockers for benign prostatic hyperplasia in older adults at risk of falls: a clinical review","volume":"14","author":"\u0130lhan","year":"2023","journal-title":"Eur Geriatr Med."},{"key":"2025081221214026700_glaf150-B17","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1111\/j.1532-5415.2005.00537.x","article-title":"Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients","volume":"53","author":"Kay","year":"2005","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B18","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergic medications and incident dementia","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med."},{"key":"2025081221214026700_glaf150-B19","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1111\/jgs.19191","article-title":"Identifying and quantifying potentially problematic prescribing cascades in clinical practice: a mixed-methods study","volume":"72","author":"Mohammad","year":"2024","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B20","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/s10654-017-0281-8","article-title":"Sequence symmetry analysis in pharmacovigilance and pharmacoepidemiologic studies","volume":"32","author":"Lai","year":"2017","journal-title":"Eur J Epidemiol."},{"key":"2025081221214026700_glaf150-B21","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1016\/j.sapharm.2021.08.003","article-title":"Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: a scoping review","volume":"18","author":"Morris","year":"2022","journal-title":"Res Soc Adm Pharm."},{"key":"2025081221214026700_glaf150-B22"},{"key":"2025081221214026700_glaf150-B23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12874-023-02108-y","article-title":"Prescription sequence symmetry analysis (PSSA) to assess prescribing cascades: a step-by-step guide","volume":"24","author":"Hendrix","year":"2024","journal-title":"BMC Med Res Methodol."},{"key":"2025081221214026700_glaf150-B24","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/MLR.0000000000001216","article-title":"Validity of race and ethnicity codes in Medicare administrative data compared with gold-standard self-reported race collected during routine home health care visits","volume":"58","author":"Jarr\u00edn","year":"2020","journal-title":"Med Care."},{"key":"2025081221214026700_glaf150-B25","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol."},{"key":"2025081221214026700_glaf150-B26","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/jgs.18161","article-title":"New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge","volume":"71","author":"Growdon","year":"2023","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jama.2020.8519","article-title":"Prevalence of psychotropic and opioid prescription fills among community-dwelling older adults with dementia in the US","volume":"324","author":"Maust","year":"2020","journal-title":"JAMA."},{"key":"2025081221214026700_glaf150-B28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2105\/AJPH.2017.304174","article-title":"Impact of dual use of department of veterans affairs and Medicare part D drug benefits on potentially unsafe opioid use","volume":"108","author":"Gellad","year":"2018","journal-title":"Am J Public Health."},{"key":"2025081221214026700_glaf150-B29","doi-asserted-by":"publisher","first-page":"593","DOI":"10.7326\/M18-0852","article-title":"Receipt of overlapping opioid and benzodiazepine prescriptions among veterans dually enrolled in Medicare Part D and VA","volume":"169","author":"Carico","year":"2018","journal-title":"Ann Intern Med."},{"key":"2025081221214026700_glaf150-B30","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1097\/00001648-199609000-00005","article-title":"Evidence of depression provoked by cardiovascular medication: a prescription sequence symmetry analysis","volume":"7","author":"Hallas","year":"1996","journal-title":"Epidemiology."},{"key":"2025081221214026700_glaf150-B31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s12874-017-0457-7","article-title":"A comparison of estimators from self-controlled case series, case-crossover design, and sequence symmetry analysis for pharmacoepidemiological studies","volume":"18","author":"Takeuchi","year":"2018","journal-title":"BMC Med Res Methodol."},{"key":"2025081221214026700_glaf150-B32","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.1736","article-title":"Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis","volume":"18","author":"Tsiropoulos","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2025081221214026700_glaf150-B33","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/pds.5578","article-title":"Recommendations on the calculation of confidence intervals for sequence symmetry analyses","volume":"32","author":"Lund","year":"2023","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2025081221214026700_glaf150-B34","doi-asserted-by":"publisher","first-page":"e1918425","DOI":"10.1001\/jamanetworkopen.2019.18425","article-title":"Magnitude of and characteristics associated with the treatment of calcium channel blocker-induced lower-extremity edema with loop diuretics","volume":"2","author":"Vouri","year":"2019","journal-title":"JAMA Netw Open."},{"key":"2025081221214026700_glaf150-B35","doi-asserted-by":"publisher","first-page":"5269","DOI":"10.1111\/bcp.15447","article-title":"Association between gabapentinoids and oedema treated with loop diuretics: a pooled sequence symmetry analysis from the USA and Denmark","volume":"88","author":"Vouri","year":"2022","journal-title":"Br J Clin Pharmacol."},{"key":"2025081221214026700_glaf150-B36","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1111\/jgs.18892","article-title":"Which older adults are at highest risk of prescribing cascades? A national study of the gabapentinoid\u2013loop diuretic cascade","volume":"72","author":"Growdon","year":"2024","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B37","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2013reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med."},{"key":"2025081221214026700_glaf150-B38","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1002\/ehf2.14012","article-title":"Do adrenergic alpha-antagonists increase the risk of poor cardiovascular outcomes? A systematic review and meta-analysis","volume":"9","author":"Sousa","year":"2022","journal-title":"ESC Heart Fail."},{"key":"2025081221214026700_glaf150-B39","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000343536","article-title":"Sex differences in the physiology and pharmacology of the lower urinary tract","volume":"6","author":"Patra","year":"2013","journal-title":"Curr Urol."},{"key":"2025081221214026700_glaf150-B40","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/RRU.S102441","article-title":"Review of the epidemiology of overactive bladder","volume":"8","author":"Eapen","year":"2016","journal-title":"Res Rep Urol"},{"key":"2025081221214026700_glaf150-B41","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/s12877-020-01774-7","article-title":"Patient and provider perspectives on the development and resolution of prescribing cascades: a qualitative study","volume":"20","author":"Farrell","year":"2020","journal-title":"BMC Geriatrics."},{"key":"2025081221214026700_glaf150-B42","doi-asserted-by":"publisher","first-page":"e0272418","DOI":"10.1371\/journal.pone.0272418","article-title":"\u201cKind of blurry\u201d: deciphering clues to prevent, investigate and manage prescribing cascades","volume":"17","author":"Farrell","year":"2022","journal-title":"PLoS One"},{"key":"2025081221214026700_glaf150-B43","first-page":"13","article-title":"Prescribing cascade. A proposed new way to evaluate it","volume":"77","author":"Ponte","year":"2017","journal-title":"Medicina (B Aires)."},{"key":"2025081221214026700_glaf150-B44","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1111\/jgs.15543","article-title":"What is known about preventing, detecting, and reversing prescribing cascades: a scoping review: scoping review on prescribing cascades","volume":"66","author":"Brath","year":"2018","journal-title":"J Am Geriatr Soc."},{"key":"2025081221214026700_glaf150-B45","doi-asserted-by":"publisher","first-page":"m261","DOI":"10.1136\/bmj.m261","article-title":"Using a clinical process map to identify prescribing cascades in your patient","volume":"368","author":"Piggott","year":"2020","journal-title":"BMJ"}],"container-title":["The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/advance-article-pdf\/doi\/10.1093\/gerona\/glaf150\/63777385\/glaf150.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/80\/8\/glaf150\/63777385\/glaf150.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article-pdf\/80\/8\/glaf150\/63777385\/glaf150.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T01:21:48Z","timestamp":1755048108000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biomedgerontology\/article\/doi\/10.1093\/gerona\/glaf150\/8203383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,7,24]]}},"URL":"https:\/\/doi.org\/10.1093\/gerona\/glaf150","relation":{},"ISSN":["1758-535X"],"issn-type":[{"value":"1758-535X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,8]]},"published":{"date-parts":[[2025,7,16]]},"article-number":"glaf150"}}